← Back to Analyst Consensus 
PRAX Buy
Praxis Precision Medicines, Inc.
Current Price —
Implied Upside —
Analysts 25
30-Day Momentum
▲ 2 upgrades / ▼ 0 downgrades / 3 reiterations from 4 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 16, 2026 | JP Morgan | initiate | — → Overweight | — | 55% |
| Oct 15, 2026 | UBS | initiate | — → Buy | — | 54% |
| Oct 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Oct 6, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Oct 6, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Sep 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 24, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Aug 21, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Aug 7, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 6, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 29, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 13, 2026 | Goldman Sachs | initiate | — → Buy | — | 54% |
| Jun 29, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jun 18, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| Jun 2, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Jun 2, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 2, 2026 | Deutsche Bank | maintain | Buy → Buy | — | 57% |
| Jun 2, 2026 | Wedbush | maintain | Underperform → Underperform | — | 58% |
| Jun 2, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Jun 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 2, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 26, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 20, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 8, 2026 | Wedbush | maintain | Underperform → Underperform | — | 58% |
| May 8, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Apr 14, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Apr 7, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 6, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Feb 24, 2026 | Wolfe Research | initiate | — → Outperform | $500 | 53% |
| Feb 20, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $305 | 54% |
| Feb 20, 2026 | Baird | maintain | Outperform → Outperform | $433 | 55% |
| Feb 20, 2026 | Truist Securities | maintain | Buy → Buy | $700 | 54% |
| Feb 20, 2026 | Wedbush | maintain | Underperform → Underperform | $130 | 58% |
| Feb 10, 2026 | Guggenheim | maintain | Buy → Buy | $800 | 52% |
| Feb 4, 2026 | Needham | maintain | Buy → Buy | $510 | 50% |
| Feb 2, 2026 | Wells Fargo | initiate | — → Equal-Weight | $282 | 54% |
| Jan 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $1,245 | 44% |
| Jan 28, 2026 | Piper Sandler | maintain | Overweight → Overweight | $1,200 | 54% |
| Jan 12, 2026 | Wedbush | maintain | Underperform → Underperform | $95 | 58% |
| Dec 29, 2025 | BTIG | maintain | Buy → Buy | $843 | 52% |
| Dec 15, 2025 | Oppenheimer | maintain | Outperform → Outperform | $750 | 52% |
| Dec 9, 2025 | Jefferies | maintain | Buy → Buy | $450 | 52% |
| Dec 9, 2025 | Guggenheim | maintain | Buy → Buy | $760 | 52% |
| Dec 8, 2025 | TD Cowen | maintain | Buy → Buy | $353 | 54% |
| Dec 8, 2025 | Truist Securities | maintain | Buy → Buy | $500 | 54% |
| Dec 8, 2025 | Needham | maintain | Buy → Buy | $315 | 50% |
| Dec 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $340 | 44% |
| Dec 8, 2025 | BTIG | maintain | Buy → Buy | $507 | 52% |
Price Target Trend
Jul 15, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days